Ciprofloxacin
- Product NDC
- 76420-928
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ciprofolxacin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Asclemed USA, Inc.
- Application
- ANDA208921
- Marketing category
- ANDA
- Substance
- CIPROFLOXACIN HYDROCHLORIDE
- Current FDA listing
- Yes
Packages
| Package NDC | Description | Marketing start | Marketing end | Sample | Status |
|---|
| 76420-928-20 | 20 TABLET in 1 BOTTLE (76420-928-20) | 20250328 | | No | Historical |
Related DailyMed Labels
| Set ID | Title | Manufacturer | Effective date | Type | Version |
|---|
| c4eecdf8-9e50-4e44-aca1-b9c19317d52a | These highlights do not include all the information needed to use CIPROFLOXACIN TABLETS safely and effectively. See full prescribing information for CIPROFLOXACIN TABLETS. CIPROFLOXACIN tablets, for oral use Initial U.S. Approval: 1987 | Asclemed USA, Inc. | ASCLEMED USA INC. DBA ENOVACHEM | 2025-03-28 | HUMAN PRESCRIPTION DRUG LABEL | 1 |